Literature DB >> 28109632

The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.

Nathan H J Bittner1, Peter F Orio2, Gregory S Merrick3, Bradley R Prestidge4, Alan Charles Hartford5, Seth A Rosenthal6.   

Abstract

Transperineal permanent brachytherapy is a safe and effective treatment option for patients with organ-confined prostate cancer. Careful adherence to established brachytherapy standards has been shown to improve the likelihood of procedural success and reduce the incidence of treatment-related morbidity. A collaborative effort of the American College of Radiology (ACR) and the American Brachytherapy Society (ABS) has produced practice parameters for LDR prostate brachytherapy. These practice parameters define the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist and dosimetrist. Factors with respect to patient selection and appropriate use of supplemental treatment modalities such as external beam radiation and androgen suppression therapy are discussed. Logistics with respect to the brachytherapy implant procedure, the importance of dosimetric guidelines, and attention to radiation safety procedures and documentation are presented. Adherence to these parameters can be part of ensuring quality and safety in a successful prostate brachytherapy program.
Copyright © 2016 American Brachytherapy Society and American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Dosimetry; Prostate cancer; Quality assurance; Safety

Mesh:

Year:  2017        PMID: 28109632     DOI: 10.1016/j.brachy.2016.06.003

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  9 in total

1.  Successful Stereotactic Body Radiation Therapy for Postbrachytherapy Prostate Recurrence and Penile Bulb Metastasis.

Authors:  Deborah E Citrin; Erica Schott; Kilian Salerno; Holly Ning; Peter A Pinto; Bradford J Wood; Liza Lindenberg; Esther Mena; Baris Turkbey
Journal:  Adv Radiat Oncol       Date:  2021-11-28

2.  CT-MR Image Fusion for Post-Implant Dosimetry Analysis in Brain Tumor Seed Implantation- a Preliminary Study.

Authors:  Menglong Zhang; Cunkun Chu; Liyin Huang; Bijuan Hu
Journal:  Dis Markers       Date:  2022-05-17       Impact factor: 3.464

Review 3.  A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.

Authors:  Michael Chao; Sandra Spencer; Mario Guerrieri; Wei Ding; Mehran Goharian; Huong Ho; Michael Ng; Danielle Healey; Alwin Tan; Chee Cham; Daryl Lim Joon; Nathan Lawrentschuk; Douglas Travis; Shomik Sengupta; Yee Chan; Andrew Troy; Trung Pham; David Clarke; Peter Liodakis; Damien Bolton
Journal:  J Contemp Brachytherapy       Date:  2018-04-30

4.  Radiothrerapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer-Is There a Role of Brachytherapy?

Authors:  Hideya Yamazaki; Koji Masui; Gen Suzuki; Satoaki Nakamura; Norihiro Aibe; Daisuke Shimizu; Tatsuyuki Nishikawa; Haruumi Okabe; Ken Yoshida; Tadayuki Kotsuma; Eiichi Tanaka; Keisuke Otani; Yasuo Yoshioka; Kazuhiko Ogawa
Journal:  J Clin Med       Date:  2018-11-08       Impact factor: 4.241

5.  Subdermal injection of hyaluronic acid to decrease skin toxicity from radiation delivered with low-dose-rate brachytherapy for cancer patients.

Authors:  Yuan Yuan; Zhang Ying; Dai Jianjian; Lin Qi; Xu Ruicai; Geng Baocheng; Han Mingyong
Journal:  J Contemp Brachytherapy       Date:  2019-02-28

6.  High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.

Authors:  Hideya Yamazaki; Koji Masui; Gen Suzuki; Norihiro Aibe; Daisuke Shimizu; Takuya Kimoto; Kei Yamada; Akihisa Ueno; Toru Matsugasumi; Yasuhiro Yamada; Takumi Shiraishi; Atsuko Fujihara; Koji Okihara; Ken Yoshida; Satoaki Nakamura
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

7.  Characteristics and risk differences of different tumor size on localized prostate cancer: A retrospective cohort study in the SEER database.

Authors:  Zhen Zhou; Feng Yue; Liang Jin; Xiang Liu; Ting-Shuai Zhai; Jia-Xin Zhang; Wen-Yu Gu; Sheng-Hua Liu; Ming Luo; Bo Peng; Xu-Dong Yao; Lin Ye
Journal:  Cancer Med       Date:  2021-03-16       Impact factor: 4.452

8.  Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants.

Authors:  Wayne M Butler; Brian S Kurko; Whitney J Scholl; Gregory S Merrick
Journal:  J Contemp Brachytherapy       Date:  2021-04-14

9.  CT-guided trans-sternal iodine-125 seeds implantation for masses in the anterior or middle mediastinum.

Authors:  Meng Wang; Feng Shi; Zhigang Zhou; Yao Cui; Kepu Du; Shuai Li; Tingting Liu; Yanlin Chen; Yadan Li; Fei Gao
Journal:  J Contemp Brachytherapy       Date:  2022-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.